Heart Attack

Avive Solutions Partners with Academy Safe: Advancing Safety Standards for Martial Arts Studios Across the U.S.

SAN FRANCISCO, Nov. 19, 2024 /PRNewswire/ -- Avive Solutions is proud to announce its partnership with Academy Safe, a non-profit organization…

4 days ago

SEEHER, ABBOTT, AND CVS RELEASE FIRST-EVER HEALTH AND WELLNESS REPORT TO COMBAT HOW WOMEN HAVE BEEN DEPRIORITIZED AND UNDERREPRESENTED IN HEALTHCARE MARKETING

Women are the key decision makers in 80% of all healthcare choices, yet many brands fail to accurately portray them…

5 days ago

FDA Grants De Novo Authorization to OMRON Healthcare for New Blood Pressure Monitors with AI-Powered AFib Detection Feature

Advancing its Going for Zero mission, OMRON innovation makes AFib screening an integral part of the brand's routine home blood…

1 week ago

SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors

TEL AVIV, Israel, Nov. 14, 2024 /PRNewswire/ -- SoniVie Ltd., a medical device company developing a proprietary renal denervation system to…

1 week ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…

1 week ago

Cumberland County and The Peyton Walker Foundation Celebrate the First Life Saved in the U.S. Using Avive Solutions’ New AED Technology

SAN FRANCISCO, Oct. 29, 2024 /PRNewswire/ -- On July 16, 2024, a life-saving event unfolded when a trained citizen volunteer…

4 weeks ago

Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024

Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans…

4 weeks ago

Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024

RADNOR, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing…

1 month ago